Novel activating and inactivating mutations in the integrin beta1 subunit A domain.
D000409:Alanine / Q000235:genetics / Q000502:physiology; D019943:Amino Acid Substitution / Q000235:genetics / Q000502:physiology; D000818:Animals; D016466:CHO Cells / Q000737:chemistry / Q000378:metabolism; D019556:COS Cells / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D006801:Humans; D019012:Integrin beta1 / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D016297:Mutagenesis, Site-Directed / Q000235:genetics / Q000502:physiology; D009154:Mutation / Q000235:genetics / Q000502:physiology*; D010455:Peptides / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D011487:Protein Conformation; D017434:Protein Structure, Tertiary / Q000235:genetics / Q000502:physiology; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D013912:Threonine / Q000235:genetics / Q000502:physiology; D014162:Transfection / Q000379:methods; D014633:Valine / Q000235:genetics / Q000502:physiology
D019012:Integrin beta1; D010455:Peptides; D011994:Recombinant Proteins; D013912:Threonine; D014633:Valine; D000409:Alanine